These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3556124)

  • 1. [Effects of gamma-oryzanol on experimental coronary atherosclerosis in rats].
    Zhang QH
    Zhonghua Xin Xue Guan Bing Za Zhi; 1986 Oct; 14(5):287-90, 319. PubMed ID: 3556124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effect of gamma-oryzanol on climacteric disturbance -on serum lipid peroxides (author's transl)].
    Ishihara M; Ito Y; Nakakita T; Maehama T; Hieda S; Yamamoto K; Ueno N
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Feb; 34(2):243-51. PubMed ID: 7061906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gamma-oryzanol on atheroma formation in hypercholesterolemic rabbits.
    Hiramatsu K; Tani T; Kimura Y; Izumi S; Nakane PK
    Tokai J Exp Clin Med; 1990 Jul; 15(4):299-305. PubMed ID: 2130537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration.
    Izutani H; Miyagawa S; Matsumiya G; Nakata S; Shimazaki Y; Matsuda H; Shirakura R
    Transplant Proc; 1995 Feb; 27(1):579-81. PubMed ID: 7533425
    [No Abstract]   [Full Text] [Related]  

  • 5. [Can the progression of coronary heart disease be modified by calcium antagonists?].
    Schneider W; Roebruck P; Kober G; Alle M; Cieslinski G; Mildenberger D; Satter P; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():112-20. PubMed ID: 2698562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gamma-oryzanol on serum lipid peroxide level and clinical symptoms of patients with climacteric disturbances.
    Ishihara M
    Asia Oceania J Obstet Gynaecol; 1984 Sep; 10(3):317-23. PubMed ID: 6525087
    [No Abstract]   [Full Text] [Related]  

  • 7. The composition of coronary-artery plaques.
    Davies MJ
    N Engl J Med; 1997 May; 336(18):1312-4. PubMed ID: 9113937
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental atherosclerosis in rat and rabbit cardiac allografts.
    Laden AM
    Arch Pathol; 1972 Mar; 93(3):240-5. PubMed ID: 4551496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of gamma-oryzanol. (2) The antiulcerogenic action].
    Itaya K; Kitonaga J; Ishikawa M
    Nihon Yakurigaku Zasshi; 1976 Nov; 72(8):1001-11. PubMed ID: 1088137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit plaque models closely resembling lesions in human coronary artery disease.
    Okabe T; Hoshiga M; Negoro N; Nakakoji T; Arishiro K; Ishihara T; Ueno H; Hanafusa T
    Int J Cardiol; 2011 Mar; 147(2):271-7. PubMed ID: 19896731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis in the back yard.
    Herrmann J; Lerman A
    J Am Coll Cardiol; 2007 May; 49(21):2102-4. PubMed ID: 17531659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of reduced cholesterol on coronary arteries].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 1998 Oct; 118(24):3805-9. PubMed ID: 9816952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Far-advanced coronary artery atherosclerosis in a 25-year-old man.
    Roman C; Gooch AS; Maranhao V
    J Am Osteopath Assoc; 1986 Aug; 86(8):496-8. PubMed ID: 3759519
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term observation of thin-cap fibroatheroma by optical coherence tomography.
    Tyczyński P; Moreno-Ambroj C; Ghilencea L; Witkowska AB; Mario CD
    Cardiol J; 2010; 17(6):634-5. PubMed ID: 21154271
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coronary atherosclerosis and pathology of restenosis following coronary artery intervention].
    Ikura Y; Ueda M
    Nihon Naika Gakkai Zasshi; 2000 Feb; 89(2):219-23. PubMed ID: 10756632
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of parmidine on the lipid peroxidation processes in coronary atherosclerosis].
    Artem'eva GB; Rakita DR; Uzbekova DG; Garbash VIa
    Farmakol Toksikol; 1990; 53(4):56-8. PubMed ID: 2226764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: results of the New Age II Pilot Study.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Baumann D; Heuschmid M; Brodoefel H; Claussen CD; Kopp AF; Schroeder S
    Invest Radiol; 2007 Mar; 42(3):189-95. PubMed ID: 17287649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytofluorometric analysis of DNA content in proliferating cells of coronary arteriosclerotic lesions].
    Kiyuna M; Toda T; Tamamoto T; Shingaki Y; Shimajiri S; Deguchi S; Muto Y
    Rinsho Byori; 1992 Nov; 40(11):1173-8. PubMed ID: 1307624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol and the coronary endothelium.
    Knight CJ; Warren JB
    J Cardiovasc Risk; 1995 Jun; 2(3):180-8. PubMed ID: 7584792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The internal mammary artery as a graft material for coronary artery bypass surgery. Histopathologic and biochemical studies of its atherosclerotic changes].
    Kobayashi H
    Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):889-900. PubMed ID: 2398882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.